Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index values

OBJECTIVE: The aim of the study was to analyze John Cunningham virus (JCV) serology in natalizumab-treated patients over time and assess whether they are influenced by natalizumab treatment. METHODS: German (n = 1,921; 525 longitudinally) and French (n = 1,259; 711 longitudinally) patients were asse...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurol Neuroimmunol Neuroinflamm
Autors principals: Schwab, Nicholas, Schneider-Hohendorf, Tilman, Pignolet, Béatrice, Breuer, Johanna, Gross, Catharina C., Göbel, Kerstin, Brassat, David, Wiendl, Heinz
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4733149/
https://ncbi.nlm.nih.gov/pubmed/26848486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000195
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars